REPORT ID 17673

Global Prostate Cancer Drugs Market Professional Survey Report 2017

Publish Date
02-Oct-17
Pages
120
Format
Electronic (PDF)

This report studies Prostate Cancer Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    AbbVie
    Astellas Pharma
    Astra Zeneca
    Johnson & Johnson
    Sanofi
    GlaxoSmithKline
    Merck Group
    Novartis
    Amgen
    Bayer HealthCare
    Ferring Pharmaceutical
    Janssen Pharmaceuticals
    Endo Pharmaceuticals
    BMS
    Takeda Pharmaceuticals
    Northwest Biotherapeutics
    Teva Pharmaceutical
    Boehringer Ingelheim
    Foresee Pharmaceuticals
    Tokai Pharmaceuticals
    Spectrum Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Hormonal Therapy
    Chemotherapy
    Immunotherapy
    Targeted Therapy

By Application, the market can be split into
    Clinics
    Hospitals
    Other

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Prostate Cancer Drugs Market Professional Survey Report 2017
1 Industry Overview of Prostate Cancer Drugs
    1.1 Definition and Specifications of Prostate Cancer Drugs
        1.1.1 Definition of Prostate Cancer Drugs
        1.1.2 Specifications of Prostate Cancer Drugs
    1.2 Classification of Prostate Cancer Drugs
        1.2.1 Hormonal Therapy
        1.2.2 Chemotherapy
        1.2.3 Immunotherapy
        1.2.4 Targeted Therapy
    1.3 Applications of Prostate Cancer Drugs
        1.3.1 Clinics
        1.3.2 Hospitals
        1.3.3 Other
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Prostate Cancer Drugs
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Prostate Cancer Drugs
    2.3 Manufacturing Process Analysis of Prostate Cancer Drugs
    2.4 Industry Chain Structure of Prostate Cancer Drugs

3 Technical Data and Manufacturing Plants Analysis of Prostate Cancer Drugs
    3.1 Capacity and Commercial Production Date of Global Prostate Cancer Drugs Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Prostate Cancer Drugs Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Prostate Cancer Drugs Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Prostate Cancer Drugs Major Manufacturers in 2016

4 Global Prostate Cancer Drugs Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Prostate Cancer Drugs Capacity and Growth Rate Analysis
        4.2.2 2016 Prostate Cancer Drugs Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Prostate Cancer Drugs Sales and Growth Rate Analysis
        4.3.2 2016 Prostate Cancer Drugs Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Prostate Cancer Drugs Sales Price
        4.4.2 2016 Prostate Cancer Drugs Sales Price Analysis (Company Segment)

5 Prostate Cancer Drugs Regional Market Analysis
    5.1 North America Prostate Cancer Drugs Market Analysis
        5.1.1 North America Prostate Cancer Drugs Market Overview
        5.1.2 North America 2012-2017E Prostate Cancer Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Prostate Cancer Drugs Sales Price Analysis
        5.1.4 North America 2016 Prostate Cancer Drugs Market Share Analysis
    5.2 China Prostate Cancer Drugs Market Analysis
        5.2.1 China Prostate Cancer Drugs Market Overview
        5.2.2 China 2012-2017E Prostate Cancer Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Prostate Cancer Drugs Sales Price Analysis
        5.2.4 China 2016 Prostate Cancer Drugs Market Share Analysis
    5.3 Europe Prostate Cancer Drugs Market Analysis
        5.3.1 Europe Prostate Cancer Drugs Market Overview
        5.3.2 Europe 2012-2017E Prostate Cancer Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Prostate Cancer Drugs Sales Price Analysis
        5.3.4 Europe 2016 Prostate Cancer Drugs Market Share Analysis
    5.4 Southeast Asia Prostate Cancer Drugs Market Analysis
        5.4.1 Southeast Asia Prostate Cancer Drugs Market Overview
        5.4.2 Southeast Asia 2012-2017E Prostate Cancer Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Prostate Cancer Drugs Sales Price Analysis
        5.4.4 Southeast Asia 2016 Prostate Cancer Drugs Market Share Analysis
    5.5 Japan Prostate Cancer Drugs Market Analysis
        5.5.1 Japan Prostate Cancer Drugs Market Overview
        5.5.2 Japan 2012-2017E Prostate Cancer Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Prostate Cancer Drugs Sales Price Analysis
        5.5.4 Japan 2016 Prostate Cancer Drugs Market Share Analysis
    5.6 India Prostate Cancer Drugs Market Analysis
        5.6.1 India Prostate Cancer Drugs Market Overview
        5.6.2 India 2012-2017E Prostate Cancer Drugs Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Prostate Cancer Drugs Sales Price Analysis
        5.6.4 India 2016 Prostate Cancer Drugs Market Share Analysis

6 Global 2012-2017E Prostate Cancer Drugs Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Prostate Cancer Drugs Sales by Type
    6.2 Different Types of Prostate Cancer Drugs Product Interview Price Analysis
    6.3 Different Types of Prostate Cancer Drugs Product Driving Factors Analysis
        6.3.1 Hormonal Therapy of Prostate Cancer Drugs Growth Driving Factor Analysis
        6.3.2 Chemotherapy of Prostate Cancer Drugs Growth Driving Factor Analysis
        6.3.3 Immunotherapy of Prostate Cancer Drugs Growth Driving Factor Analysis
        6.3.4 Targeted Therapy of Prostate Cancer Drugs Growth Driving Factor Analysis

7 Global 2012-2017E Prostate Cancer Drugs Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Prostate Cancer Drugs Consumption by Application
    7.2 Different Application of Prostate Cancer Drugs Product Interview Price Analysis
    7.3 Different Application of Prostate Cancer Drugs Product Driving Factors Analysis
        7.3.1 Clinics of Prostate Cancer Drugs Growth Driving Factor Analysis
        7.3.2 Hospitals of Prostate Cancer Drugs Growth Driving Factor Analysis
        7.3.3 Other of Prostate Cancer Drugs Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Prostate Cancer Drugs
    8.1 AbbVie
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 AbbVie 2016 Prostate Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 AbbVie 2016 Prostate Cancer Drugs Business Region Distribution Analysis
    8.2 Astellas Pharma
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Astellas Pharma 2016 Prostate Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Astellas Pharma 2016 Prostate Cancer Drugs Business Region Distribution Analysis
    8.3 Astra Zeneca
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Astra Zeneca 2016 Prostate Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Astra Zeneca 2016 Prostate Cancer Drugs Business Region Distribution Analysis
    8.4 Johnson & Johnson
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Johnson & Johnson 2016 Prostate Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Johnson & Johnson 2016 Prostate Cancer Drugs Business Region Distribution Analysis
    8.5 Sanofi
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Sanofi 2016 Prostate Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Sanofi 2016 Prostate Cancer Drugs Business Region Distribution Analysis
    8.6 GlaxoSmithKline
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 GlaxoSmithKline 2016 Prostate Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 GlaxoSmithKline 2016 Prostate Cancer Drugs Business Region Distribution Analysis
    8.7 Merck Group
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 Merck Group 2016 Prostate Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 Merck Group 2016 Prostate Cancer Drugs Business Region Distribution Analysis
    8.8 Novartis
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Novartis 2016 Prostate Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Novartis 2016 Prostate Cancer Drugs Business Region Distribution Analysis
    8.9 Amgen
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 Amgen 2016 Prostate Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Amgen 2016 Prostate Cancer Drugs Business Region Distribution Analysis
    8.10 Bayer HealthCare
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Bayer HealthCare 2016 Prostate Cancer Drugs Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Bayer HealthCare 2016 Prostate Cancer Drugs Business Region Distribution Analysis
    8.11 Ferring Pharmaceutical
    8.12 Janssen Pharmaceuticals
    8.13 Endo Pharmaceuticals
    8.14 BMS
    8.15 Takeda Pharmaceuticals
    8.16 Northwest Biotherapeutics
    8.17 Teva Pharmaceutical
    8.18 Boehringer Ingelheim
    8.19 Foresee Pharmaceuticals
    8.20 Tokai Pharmaceuticals
    8.21 Spectrum Pharmaceuticals

9 Development Trend of Analysis of Prostate Cancer Drugs Market
    9.1 Global Prostate Cancer Drugs Market Trend Analysis
        9.1.1 Global 2017-2022 Prostate Cancer Drugs Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Prostate Cancer Drugs Sales Price Forecast
    9.2 Prostate Cancer Drugs Regional Market Trend
        9.2.1 North America 2017-2022 Prostate Cancer Drugs Consumption Forecast
        9.2.2 China 2017-2022 Prostate Cancer Drugs Consumption Forecast
        9.2.3 Europe 2017-2022 Prostate Cancer Drugs Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Prostate Cancer Drugs Consumption Forecast
        9.2.5 Japan 2017-2022 Prostate Cancer Drugs Consumption Forecast
        9.2.6 India 2017-2022 Prostate Cancer Drugs Consumption Forecast
    9.3 Prostate Cancer Drugs Market Trend (Product Type)
    9.4 Prostate Cancer Drugs Market Trend (Application)

10 Prostate Cancer Drugs Marketing Type Analysis
    10.1 Prostate Cancer Drugs Regional Marketing Type Analysis
    10.2 Prostate Cancer Drugs International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Prostate Cancer Drugs by Region
    10.4 Prostate Cancer Drugs Supply Chain Analysis

11 Consumers Analysis of Prostate Cancer Drugs
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis
    ?

12 Conclusion of the Global Prostate Cancer Drugs Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source